nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—Microtubule Inhibition—Docetaxel—ovarian cancer	0.223	1	CiPCiCtD
Paclitaxel—Docetaxel—ovarian cancer	0.21	1	CrCtD
Paclitaxel—breast cancer—ovarian cancer	0.128	1	CtDrD
Paclitaxel—Cabazitaxel—Docetaxel—ovarian cancer	0.12	1	CrCrCtD
Paclitaxel—TUBB3—ovarian cancer	0.0623	0.635	CbGaD
Paclitaxel—CYP1B1—ovarian cancer	0.0278	0.284	CbGaD
Paclitaxel—MAP4—Docetaxel—ovarian cancer	0.0114	0.0741	CbGbCtD
Paclitaxel—MAPT—Docetaxel—ovarian cancer	0.00825	0.0536	CbGbCtD
Paclitaxel—MAP2—Docetaxel—ovarian cancer	0.00825	0.0536	CbGbCtD
Paclitaxel—ABCB1—ovarian cancer	0.00799	0.0814	CbGaD
Paclitaxel—TUBB3—Vinorelbine—ovarian cancer	0.00741	0.0481	CbGbCtD
Paclitaxel—TUBB2B—Vinorelbine—ovarian cancer	0.00741	0.0481	CbGbCtD
Paclitaxel—TUBB6—Vinorelbine—ovarian cancer	0.00741	0.0481	CbGbCtD
Paclitaxel—TUBB4A—Vinorelbine—ovarian cancer	0.00741	0.0481	CbGbCtD
Paclitaxel—TUBB2A—Vinorelbine—ovarian cancer	0.00741	0.0481	CbGbCtD
Paclitaxel—TUBB8—Vinorelbine—ovarian cancer	0.00741	0.0481	CbGbCtD
Paclitaxel—BCL2—Docetaxel—ovarian cancer	0.00655	0.0426	CbGbCtD
Paclitaxel—TUBB1—Vinorelbine—ovarian cancer	0.0062	0.0402	CbGbCtD
Paclitaxel—TUBB4B—Vinorelbine—ovarian cancer	0.0062	0.0402	CbGbCtD
Paclitaxel—TUBB—Vinorelbine—ovarian cancer	0.0062	0.0402	CbGbCtD
Paclitaxel—TUBB2A—Docetaxel—ovarian cancer	0.00376	0.0244	CbGbCtD
Paclitaxel—TUBB6—Docetaxel—ovarian cancer	0.00376	0.0244	CbGbCtD
Paclitaxel—TUBB3—Docetaxel—ovarian cancer	0.00376	0.0244	CbGbCtD
Paclitaxel—TUBB2B—Docetaxel—ovarian cancer	0.00376	0.0244	CbGbCtD
Paclitaxel—TUBB8—Docetaxel—ovarian cancer	0.00376	0.0244	CbGbCtD
Paclitaxel—TUBB4A—Docetaxel—ovarian cancer	0.00376	0.0244	CbGbCtD
Paclitaxel—NR1I2—Docetaxel—ovarian cancer	0.00342	0.0222	CbGbCtD
Paclitaxel—TUBB1—Docetaxel—ovarian cancer	0.00315	0.0204	CbGbCtD
Paclitaxel—TUBB4B—Docetaxel—ovarian cancer	0.00315	0.0204	CbGbCtD
Paclitaxel—TUBB—Docetaxel—ovarian cancer	0.00315	0.0204	CbGbCtD
Paclitaxel—ABCC10—Docetaxel—ovarian cancer	0.00241	0.0156	CbGbCtD
Paclitaxel—ABCC10—Doxorubicin—ovarian cancer	0.00179	0.0116	CbGbCtD
Paclitaxel—ABCG2—Topotecan—ovarian cancer	0.00174	0.0113	CbGbCtD
Paclitaxel—CYP19A1—follicular fluid—ovarian cancer	0.00135	0.0886	CbGeAlD
Paclitaxel—SLCO1B3—Docetaxel—ovarian cancer	0.00134	0.00872	CbGbCtD
Paclitaxel—CYP1B1—Docetaxel—ovarian cancer	0.00131	0.00849	CbGbCtD
Paclitaxel—ABCC1—Epirubicin—ovarian cancer	0.0013	0.00846	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—ovarian cancer	0.000974	0.00633	CbGbCtD
Paclitaxel—ABCB11—Doxorubicin—ovarian cancer	0.000974	0.00633	CbGbCtD
Paclitaxel—ABCC1—Docetaxel—ovarian cancer	0.000929	0.00603	CbGbCtD
Paclitaxel—ABCC2—Carboplatin—ovarian cancer	0.000895	0.00581	CbGbCtD
Paclitaxel—ABCG2—Carboplatin—ovarian cancer	0.000809	0.00525	CbGbCtD
Paclitaxel—CYP19A1—corpus luteum—ovarian cancer	0.000776	0.0511	CbGeAlD
Paclitaxel—ABCC1—Doxorubicin—ovarian cancer	0.000692	0.0045	CbGbCtD
Paclitaxel—ABCC2—Docetaxel—ovarian cancer	0.000687	0.00446	CbGbCtD
Paclitaxel—ABCB1—Topotecan—ovarian cancer	0.000626	0.00407	CbGbCtD
Paclitaxel—ABCG2—Docetaxel—ovarian cancer	0.000621	0.00404	CbGbCtD
Paclitaxel—CYP19A1—ovarian follicle—ovarian cancer	0.000607	0.0399	CbGeAlD
Paclitaxel—ABCC2—Doxorubicin—ovarian cancer	0.000512	0.00333	CbGbCtD
Paclitaxel—BCL2—Irinotecan—Topotecan—ovarian cancer	0.00047	1	CbGdCrCtD
Paclitaxel—ABCG2—Doxorubicin—ovarian cancer	0.000463	0.00301	CbGbCtD
Paclitaxel—CYP3A7—Docetaxel—ovarian cancer	0.000459	0.00298	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.000459	0.00298	CbGbCtD
Paclitaxel—ABCB1—Vinorelbine—ovarian cancer	0.000441	0.00286	CbGbCtD
Paclitaxel—CYP3A4—Topotecan—ovarian cancer	0.000375	0.00244	CbGbCtD
Paclitaxel—Cabazitaxel—TUBB3—ovarian cancer	0.000355	0.365	CrCbGaD
Paclitaxel—CYP3A5—Docetaxel—ovarian cancer	0.000344	0.00224	CbGbCtD
Paclitaxel—TUBB4B—oviduct—ovarian cancer	0.000315	0.0207	CbGeAlD
Paclitaxel—Docetaxel—TUBB3—ovarian cancer	0.000287	0.295	CrCbGaD
Paclitaxel—CYP3A4—Vinorelbine—ovarian cancer	0.000264	0.00172	CbGbCtD
Paclitaxel—ABCB1—Docetaxel—ovarian cancer	0.000224	0.00146	CbGbCtD
Paclitaxel—MAP4—embryo—ovarian cancer	0.000204	0.0134	CbGeAlD
Paclitaxel—MAP2—myometrium—ovarian cancer	0.000167	0.011	CbGeAlD
Paclitaxel—ABCB1—Doxorubicin—ovarian cancer	0.000167	0.00108	CbGbCtD
Paclitaxel—MAP4—uterine cervix—ovarian cancer	0.000165	0.0109	CbGeAlD
Paclitaxel—MAP2—embryo—ovarian cancer	0.000161	0.0106	CbGeAlD
Paclitaxel—MAP4—decidua—ovarian cancer	0.000157	0.0103	CbGeAlD
Paclitaxel—TUBB1—decidua—ovarian cancer	0.000154	0.0101	CbGeAlD
Paclitaxel—BCL2—epithelium—ovarian cancer	0.000151	0.00996	CbGeAlD
Paclitaxel—TUBB8—testis—ovarian cancer	0.000146	0.00963	CbGeAlD
Paclitaxel—MAP4—gonad—ovarian cancer	0.000139	0.00911	CbGeAlD
Paclitaxel—MAP4—uterus—ovarian cancer	0.000138	0.00905	CbGeAlD
Paclitaxel—BCL2—endometrium—ovarian cancer	0.000136	0.00893	CbGeAlD
Paclitaxel—CYP3A4—Docetaxel—ovarian cancer	0.000134	0.000872	CbGbCtD
Paclitaxel—MAP2—uterine cervix—ovarian cancer	0.00013	0.00855	CbGeAlD
Paclitaxel—Docetaxel—CYP1B1—ovarian cancer	0.000128	0.132	CrCbGaD
Paclitaxel—MAPT—testis—ovarian cancer	0.000127	0.00835	CbGeAlD
Paclitaxel—BCL2—gonad—ovarian cancer	0.000126	0.00828	CbGeAlD
Paclitaxel—BCL2—uterus—ovarian cancer	0.000125	0.00823	CbGeAlD
Paclitaxel—TUBB2B—myometrium—ovarian cancer	0.000125	0.00821	CbGeAlD
Paclitaxel—TUBB4A—embryo—ovarian cancer	0.000124	0.00817	CbGeAlD
Paclitaxel—MAP2—decidua—ovarian cancer	0.000124	0.00815	CbGeAlD
Paclitaxel—MAP4—female reproductive system—ovarian cancer	0.000124	0.00814	CbGeAlD
Paclitaxel—Docetaxel—EGFR—ovarian cancer	0.000121	0.124	CrCbGaD
Paclitaxel—TUBB—myometrium—ovarian cancer	0.000118	0.00777	CbGeAlD
Paclitaxel—MAP2—endometrium—ovarian cancer	0.000118	0.00774	CbGeAlD
Paclitaxel—TUBB2A—myometrium—ovarian cancer	0.000118	0.00773	CbGeAlD
Paclitaxel—TUBB6—myometrium—ovarian cancer	0.000116	0.00762	CbGeAlD
Paclitaxel—TUBB1—bone marrow—ovarian cancer	0.000114	0.00751	CbGeAlD
Paclitaxel—MAP4—female gonad—ovarian cancer	0.000113	0.00741	CbGeAlD
Paclitaxel—BCL2—female reproductive system—ovarian cancer	0.000113	0.0074	CbGeAlD
Paclitaxel—MAP4—vagina—ovarian cancer	0.000112	0.00736	CbGeAlD
Paclitaxel—MAP2—gonad—ovarian cancer	0.000109	0.00718	CbGeAlD
Paclitaxel—BCL2—bone marrow—ovarian cancer	0.000106	0.00698	CbGeAlD
Paclitaxel—BCL2—female gonad—ovarian cancer	0.000102	0.00673	CbGeAlD
Paclitaxel—ABCC10—myometrium—ovarian cancer	0.000101	0.00667	CbGeAlD
Paclitaxel—TUBB4B—myometrium—ovarian cancer	0.000101	0.00663	CbGeAlD
Paclitaxel—TUBB4A—uterine cervix—ovarian cancer	0.000101	0.00661	CbGeAlD
Paclitaxel—CYP3A4—Doxorubicin—ovarian cancer	0.0001	0.00065	CbGbCtD
Paclitaxel—TUBB3—testis—ovarian cancer	9.99e-05	0.00657	CbGeAlD
Paclitaxel—MAP4—testis—ovarian cancer	9.99e-05	0.00657	CbGeAlD
Paclitaxel—SLCO1B3—vagina—ovarian cancer	9.8e-05	0.00644	CbGeAlD
Paclitaxel—TUBB1—testis—ovarian cancer	9.77e-05	0.00642	CbGeAlD
Paclitaxel—MAP2—female reproductive system—ovarian cancer	9.75e-05	0.00641	CbGeAlD
Paclitaxel—TUBB2B—uterine cervix—ovarian cancer	9.72e-05	0.00639	CbGeAlD
Paclitaxel—TUBB4B—embryo—ovarian cancer	9.69e-05	0.00637	CbGeAlD
Paclitaxel—MAPT—lymph node—ovarian cancer	9.21e-05	0.00606	CbGeAlD
Paclitaxel—TUBB—uterine cervix—ovarian cancer	9.19e-05	0.00605	CbGeAlD
Paclitaxel—TUBB2A—uterine cervix—ovarian cancer	9.15e-05	0.00601	CbGeAlD
Paclitaxel—TUBB6—epithelium—ovarian cancer	9.1e-05	0.00598	CbGeAlD
Paclitaxel—BCL2—testis—ovarian cancer	9.08e-05	0.00597	CbGeAlD
Paclitaxel—TUBB6—uterine cervix—ovarian cancer	9.02e-05	0.00593	CbGeAlD
Paclitaxel—MAP2—female gonad—ovarian cancer	8.87e-05	0.00583	CbGeAlD
Paclitaxel—MAP2—vagina—ovarian cancer	8.81e-05	0.0058	CbGeAlD
Paclitaxel—TUBB2B—endometrium—ovarian cancer	8.79e-05	0.00578	CbGeAlD
Paclitaxel—TUBB—decidua—ovarian cancer	8.76e-05	0.00576	CbGeAlD
Paclitaxel—TUBB2A—decidua—ovarian cancer	8.71e-05	0.00573	CbGeAlD
Paclitaxel—TUBB6—decidua—ovarian cancer	8.59e-05	0.00565	CbGeAlD
Paclitaxel—TUBB4A—gonad—ovarian cancer	8.43e-05	0.00555	CbGeAlD
Paclitaxel—TUBB4A—uterus—ovarian cancer	8.38e-05	0.00551	CbGeAlD
Paclitaxel—TUBB—endometrium—ovarian cancer	8.32e-05	0.00547	CbGeAlD
Paclitaxel—TUBB2A—endometrium—ovarian cancer	8.27e-05	0.00544	CbGeAlD
Paclitaxel—TUBB6—endometrium—ovarian cancer	8.16e-05	0.00536	CbGeAlD
Paclitaxel—TUBB2B—gonad—ovarian cancer	8.15e-05	0.00536	CbGeAlD
Paclitaxel—ABCC10—uterine cervix—ovarian cancer	7.9e-05	0.00519	CbGeAlD
Paclitaxel—MAP2—testis—ovarian cancer	7.87e-05	0.00517	CbGeAlD
Paclitaxel—TUBB4B—uterine cervix—ovarian cancer	7.84e-05	0.00516	CbGeAlD
Paclitaxel—TUBB—uterus—ovarian cancer	7.66e-05	0.00504	CbGeAlD
Paclitaxel—TUBB2A—uterus—ovarian cancer	7.62e-05	0.00501	CbGeAlD
Paclitaxel—TUBB6—gonad—ovarian cancer	7.57e-05	0.00498	CbGeAlD
Paclitaxel—ABCB11—testis—ovarian cancer	7.54e-05	0.00496	CbGeAlD
Paclitaxel—TUBB4A—female reproductive system—ovarian cancer	7.53e-05	0.00495	CbGeAlD
Paclitaxel—ABCC10—decidua—ovarian cancer	7.52e-05	0.00495	CbGeAlD
Paclitaxel—TUBB6—uterus—ovarian cancer	7.52e-05	0.00494	CbGeAlD
Paclitaxel—TUBB4B—decidua—ovarian cancer	7.47e-05	0.00491	CbGeAlD
Paclitaxel—TUBB2B—female reproductive system—ovarian cancer	7.28e-05	0.00479	CbGeAlD
Paclitaxel—MAP4—lymph node—ovarian cancer	7.24e-05	0.00476	CbGeAlD
Paclitaxel—ABCC1—myometrium—ovarian cancer	7.18e-05	0.00472	CbGeAlD
Paclitaxel—ABCC10—endometrium—ovarian cancer	7.14e-05	0.0047	CbGeAlD
Paclitaxel—TUBB4B—endometrium—ovarian cancer	7.09e-05	0.00466	CbGeAlD
Paclitaxel—TUBB4A—female gonad—ovarian cancer	6.85e-05	0.00451	CbGeAlD
Paclitaxel—TUBB2A—female reproductive system—ovarian cancer	6.85e-05	0.00451	CbGeAlD
Paclitaxel—TUBB6—female reproductive system—ovarian cancer	6.76e-05	0.00444	CbGeAlD
Paclitaxel—ABCC10—gonad—ovarian cancer	6.63e-05	0.00436	CbGeAlD
Paclitaxel—TUBB2B—female gonad—ovarian cancer	6.62e-05	0.00436	CbGeAlD
Paclitaxel—TUBB2B—vagina—ovarian cancer	6.58e-05	0.00433	CbGeAlD
Paclitaxel—ABCC10—uterus—ovarian cancer	6.58e-05	0.00433	CbGeAlD
Paclitaxel—BCL2—lymph node—ovarian cancer	6.58e-05	0.00433	CbGeAlD
Paclitaxel—TUBB4B—gonad—ovarian cancer	6.58e-05	0.00433	CbGeAlD
Paclitaxel—TUBB4B—uterus—ovarian cancer	6.53e-05	0.0043	CbGeAlD
Paclitaxel—TUBB—bone marrow—ovarian cancer	6.5e-05	0.00428	CbGeAlD
Paclitaxel—TUBB2A—bone marrow—ovarian cancer	6.47e-05	0.00425	CbGeAlD
Paclitaxel—TUBB6—bone marrow—ovarian cancer	6.38e-05	0.0042	CbGeAlD
Paclitaxel—TUBB—female gonad—ovarian cancer	6.27e-05	0.00412	CbGeAlD
Paclitaxel—TUBB2A—female gonad—ovarian cancer	6.23e-05	0.0041	CbGeAlD
Paclitaxel—TUBB—vagina—ovarian cancer	6.23e-05	0.0041	CbGeAlD
Paclitaxel—TUBB2A—vagina—ovarian cancer	6.2e-05	0.00407	CbGeAlD
Paclitaxel—TUBB6—female gonad—ovarian cancer	6.15e-05	0.00404	CbGeAlD
Paclitaxel—TUBB6—vagina—ovarian cancer	6.11e-05	0.00402	CbGeAlD
Paclitaxel—TUBB4A—testis—ovarian cancer	6.08e-05	0.004	CbGeAlD
Paclitaxel—CYP19A1—endometrium—ovarian cancer	6.01e-05	0.00395	CbGeAlD
Paclitaxel—ABCG2—myometrium—ovarian cancer	5.94e-05	0.00391	CbGeAlD
Paclitaxel—ABCC10—female reproductive system—ovarian cancer	5.92e-05	0.00389	CbGeAlD
Paclitaxel—CYP1B1—decidua—ovarian cancer	5.92e-05	0.00389	CbGeAlD
Paclitaxel—TUBB2B—testis—ovarian cancer	5.87e-05	0.00386	CbGeAlD
Paclitaxel—TUBB4B—female reproductive system—ovarian cancer	5.87e-05	0.00386	CbGeAlD
Paclitaxel—MAP2—lymph node—ovarian cancer	5.7e-05	0.00375	CbGeAlD
Paclitaxel—ABCC10—bone marrow—ovarian cancer	5.59e-05	0.00367	CbGeAlD
Paclitaxel—ABCC1—uterine cervix—ovarian cancer	5.59e-05	0.00367	CbGeAlD
Paclitaxel—CYP19A1—gonad—ovarian cancer	5.57e-05	0.00366	CbGeAlD
Paclitaxel—TUBB—testis—ovarian cancer	5.56e-05	0.00366	CbGeAlD
Paclitaxel—TUBB4B—bone marrow—ovarian cancer	5.55e-05	0.00365	CbGeAlD
Paclitaxel—CYP19A1—uterus—ovarian cancer	5.54e-05	0.00364	CbGeAlD
Paclitaxel—TUBB2A—testis—ovarian cancer	5.53e-05	0.00364	CbGeAlD
Paclitaxel—TUBB6—testis—ovarian cancer	5.45e-05	0.00359	CbGeAlD
Paclitaxel—ABCC10—female gonad—ovarian cancer	5.38e-05	0.00354	CbGeAlD
Paclitaxel—ABCC10—vagina—ovarian cancer	5.35e-05	0.00352	CbGeAlD
Paclitaxel—TUBB4B—female gonad—ovarian cancer	5.35e-05	0.00351	CbGeAlD
Paclitaxel—ABCC1—decidua—ovarian cancer	5.32e-05	0.0035	CbGeAlD
Paclitaxel—TUBB4B—vagina—ovarian cancer	5.31e-05	0.00349	CbGeAlD
Paclitaxel—CYP1B1—gonad—ovarian cancer	5.21e-05	0.00343	CbGeAlD
Paclitaxel—CYP1B1—uterus—ovarian cancer	5.18e-05	0.0034	CbGeAlD
Paclitaxel—ABCC1—endometrium—ovarian cancer	5.05e-05	0.00332	CbGeAlD
Paclitaxel—CYP19A1—female reproductive system—ovarian cancer	4.98e-05	0.00327	CbGeAlD
Paclitaxel—ABCC10—testis—ovarian cancer	4.78e-05	0.00314	CbGeAlD
Paclitaxel—ABCC2—female reproductive system—ovarian cancer	4.75e-05	0.00312	CbGeAlD
Paclitaxel—TUBB4B—testis—ovarian cancer	4.74e-05	0.00312	CbGeAlD
Paclitaxel—ABCC1—uterus—ovarian cancer	4.66e-05	0.00306	CbGeAlD
Paclitaxel—CYP1B1—female reproductive system—ovarian cancer	4.65e-05	0.00306	CbGeAlD
Paclitaxel—ABCG2—uterine cervix—ovarian cancer	4.62e-05	0.00304	CbGeAlD
Paclitaxel—Cabazitaxel—ABCB1—ovarian cancer	4.55e-05	0.0468	CrCbGaD
Paclitaxel—CYP19A1—female gonad—ovarian cancer	4.53e-05	0.00298	CbGeAlD
Paclitaxel—ABCG2—decidua—ovarian cancer	4.41e-05	0.0029	CbGeAlD
Paclitaxel—TUBB4A—lymph node—ovarian cancer	4.41e-05	0.0029	CbGeAlD
Paclitaxel—CYP2C8—endometrium—ovarian cancer	4.3e-05	0.00283	CbGeAlD
Paclitaxel—CYP3A5—uterine cervix—ovarian cancer	4.29e-05	0.00282	CbGeAlD
Paclitaxel—TUBB2B—lymph node—ovarian cancer	4.26e-05	0.0028	CbGeAlD
Paclitaxel—CYP1B1—female gonad—ovarian cancer	4.23e-05	0.00278	CbGeAlD
Paclitaxel—ABCG2—endometrium—ovarian cancer	4.18e-05	0.00275	CbGeAlD
Paclitaxel—TUBB—lymph node—ovarian cancer	4.03e-05	0.00265	CbGeAlD
Paclitaxel—CYP19A1—testis—ovarian cancer	4.02e-05	0.00264	CbGeAlD
Paclitaxel—TUBB2A—lymph node—ovarian cancer	4.01e-05	0.00264	CbGeAlD
Paclitaxel—TUBB6—lymph node—ovarian cancer	3.95e-05	0.0026	CbGeAlD
Paclitaxel—ABCG2—uterus—ovarian cancer	3.85e-05	0.00253	CbGeAlD
Paclitaxel—ABCC2—testis—ovarian cancer	3.83e-05	0.00252	CbGeAlD
Paclitaxel—ABCC1—female gonad—ovarian cancer	3.81e-05	0.0025	CbGeAlD
Paclitaxel—ABCC1—vagina—ovarian cancer	3.78e-05	0.00249	CbGeAlD
Paclitaxel—CYP1B1—testis—ovarian cancer	3.76e-05	0.00247	CbGeAlD
Paclitaxel—Docetaxel—ABCB1—ovarian cancer	3.68e-05	0.0378	CrCbGaD
Paclitaxel—CYP2C8—female reproductive system—ovarian cancer	3.56e-05	0.00234	CbGeAlD
Paclitaxel—ABCC10—lymph node—ovarian cancer	3.46e-05	0.00228	CbGeAlD
Paclitaxel—TUBB4B—lymph node—ovarian cancer	3.44e-05	0.00226	CbGeAlD
Paclitaxel—ABCC1—testis—ovarian cancer	3.38e-05	0.00222	CbGeAlD
Paclitaxel—ABCG2—bone marrow—ovarian cancer	3.27e-05	0.00215	CbGeAlD
Paclitaxel—CYP2C8—vagina—ovarian cancer	3.22e-05	0.00212	CbGeAlD
Paclitaxel—CYP2C9—female reproductive system—ovarian cancer	3.17e-05	0.00208	CbGeAlD
Paclitaxel—ABCG2—female gonad—ovarian cancer	3.15e-05	0.00207	CbGeAlD
Paclitaxel—ABCG2—vagina—ovarian cancer	3.13e-05	0.00206	CbGeAlD
Paclitaxel—ABCB1—myometrium—ovarian cancer	2.93e-05	0.00193	CbGeAlD
Paclitaxel—CYP3A5—female gonad—ovarian cancer	2.93e-05	0.00192	CbGeAlD
Paclitaxel—CYP19A1—lymph node—ovarian cancer	2.91e-05	0.00191	CbGeAlD
Paclitaxel—CYP3A5—vagina—ovarian cancer	2.91e-05	0.00191	CbGeAlD
Paclitaxel—CYP2C8—testis—ovarian cancer	2.88e-05	0.00189	CbGeAlD
Paclitaxel—ABCB1—embryo—ovarian cancer	2.82e-05	0.00185	CbGeAlD
Paclitaxel—ABCG2—testis—ovarian cancer	2.8e-05	0.00184	CbGeAlD
Paclitaxel—ABCC2—lymph node—ovarian cancer	2.78e-05	0.00183	CbGeAlD
Paclitaxel—CYP1B1—lymph node—ovarian cancer	2.72e-05	0.00179	CbGeAlD
Paclitaxel—ABCC1—lymph node—ovarian cancer	2.45e-05	0.00161	CbGeAlD
Paclitaxel—CYP3A4—female reproductive system—ovarian cancer	2.41e-05	0.00159	CbGeAlD
Paclitaxel—ABCB1—epithelium—ovarian cancer	2.3e-05	0.00151	CbGeAlD
Paclitaxel—ABCB1—uterine cervix—ovarian cancer	2.28e-05	0.0015	CbGeAlD
Paclitaxel—ABCB1—decidua—ovarian cancer	2.17e-05	0.00143	CbGeAlD
Paclitaxel—ABCB1—endometrium—ovarian cancer	2.06e-05	0.00136	CbGeAlD
Paclitaxel—ABCG2—lymph node—ovarian cancer	2.03e-05	0.00133	CbGeAlD
Paclitaxel—ABCB1—gonad—ovarian cancer	1.91e-05	0.00126	CbGeAlD
Paclitaxel—ABCB1—uterus—ovarian cancer	1.9e-05	0.00125	CbGeAlD
Paclitaxel—ABCB1—female reproductive system—ovarian cancer	1.71e-05	0.00112	CbGeAlD
Paclitaxel—ABCB1—bone marrow—ovarian cancer	1.61e-05	0.00106	CbGeAlD
Paclitaxel—ABCB1—female gonad—ovarian cancer	1.55e-05	0.00102	CbGeAlD
Paclitaxel—ABCB1—vagina—ovarian cancer	1.55e-05	0.00102	CbGeAlD
Paclitaxel—ABCB1—testis—ovarian cancer	1.38e-05	0.000907	CbGeAlD
Paclitaxel—ABCB1—lymph node—ovarian cancer	9.99e-06	0.000657	CbGeAlD
Paclitaxel—Arthralgia—Docetaxel—ovarian cancer	8.12e-06	0.00026	CcSEcCtD
Paclitaxel—Myalgia—Docetaxel—ovarian cancer	8.12e-06	0.00026	CcSEcCtD
Paclitaxel—Pancytopenia—Doxorubicin—ovarian cancer	8.12e-06	0.00026	CcSEcCtD
Paclitaxel—Nausea—Vinorelbine—ovarian cancer	8.11e-06	0.00026	CcSEcCtD
Paclitaxel—Renal failure—Epirubicin—ovarian cancer	8.1e-06	0.000259	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Epirubicin—ovarian cancer	8.07e-06	0.000259	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	8.07e-06	0.000258	CcSEcCtD
Paclitaxel—Stomatitis—Epirubicin—ovarian cancer	8.03e-06	0.000257	CcSEcCtD
Paclitaxel—Urinary tract infection—Epirubicin—ovarian cancer	8.01e-06	0.000256	CcSEcCtD
Paclitaxel—Conjunctivitis—Epirubicin—ovarian cancer	8.01e-06	0.000256	CcSEcCtD
Paclitaxel—Dysuria—Doxorubicin—ovarian cancer	7.99e-06	0.000256	CcSEcCtD
Paclitaxel—Neutropenia—Doxorubicin—ovarian cancer	7.99e-06	0.000256	CcSEcCtD
Paclitaxel—Dry mouth—Docetaxel—ovarian cancer	7.94e-06	0.000254	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Doxorubicin—ovarian cancer	7.94e-06	0.000254	CcSEcCtD
Paclitaxel—Pollakiuria—Doxorubicin—ovarian cancer	7.9e-06	0.000253	CcSEcCtD
Paclitaxel—Haematuria—Epirubicin—ovarian cancer	7.85e-06	0.000251	CcSEcCtD
Paclitaxel—Confusional state—Docetaxel—ovarian cancer	7.85e-06	0.000251	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Doxorubicin—ovarian cancer	7.8e-06	0.00025	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Epirubicin—ovarian cancer	7.79e-06	0.000249	CcSEcCtD
Paclitaxel—Anaphylactic shock—Docetaxel—ovarian cancer	7.79e-06	0.000249	CcSEcCtD
Paclitaxel—Oedema—Docetaxel—ovarian cancer	7.79e-06	0.000249	CcSEcCtD
Paclitaxel—Weight increased—Doxorubicin—ovarian cancer	7.78e-06	0.000249	CcSEcCtD
Paclitaxel—Epistaxis—Epirubicin—ovarian cancer	7.77e-06	0.000249	CcSEcCtD
Paclitaxel—Infection—Docetaxel—ovarian cancer	7.74e-06	0.000248	CcSEcCtD
Paclitaxel—Weight decreased—Doxorubicin—ovarian cancer	7.73e-06	0.000248	CcSEcCtD
Paclitaxel—Sinusitis—Epirubicin—ovarian cancer	7.73e-06	0.000247	CcSEcCtD
Paclitaxel—Hyperglycaemia—Doxorubicin—ovarian cancer	7.71e-06	0.000247	CcSEcCtD
Paclitaxel—Pneumonia—Doxorubicin—ovarian cancer	7.66e-06	0.000245	CcSEcCtD
Paclitaxel—Shock—Docetaxel—ovarian cancer	7.66e-06	0.000245	CcSEcCtD
Paclitaxel—Nervous system disorder—Docetaxel—ovarian cancer	7.64e-06	0.000245	CcSEcCtD
Paclitaxel—Thrombocytopenia—Docetaxel—ovarian cancer	7.62e-06	0.000244	CcSEcCtD
Paclitaxel—Infestation NOS—Doxorubicin—ovarian cancer	7.62e-06	0.000244	CcSEcCtD
Paclitaxel—Infestation—Doxorubicin—ovarian cancer	7.62e-06	0.000244	CcSEcCtD
Paclitaxel—Tachycardia—Docetaxel—ovarian cancer	7.6e-06	0.000243	CcSEcCtD
Paclitaxel—Skin disorder—Docetaxel—ovarian cancer	7.56e-06	0.000242	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	7.55e-06	0.000242	CcSEcCtD
Paclitaxel—Bradycardia—Epirubicin—ovarian cancer	7.53e-06	0.000241	CcSEcCtD
Paclitaxel—Renal failure—Doxorubicin—ovarian cancer	7.49e-06	0.00024	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Doxorubicin—ovarian cancer	7.47e-06	0.000239	CcSEcCtD
Paclitaxel—Haemoglobin—Epirubicin—ovarian cancer	7.43e-06	0.000238	CcSEcCtD
Paclitaxel—Stomatitis—Doxorubicin—ovarian cancer	7.43e-06	0.000238	CcSEcCtD
Paclitaxel—Anorexia—Docetaxel—ovarian cancer	7.42e-06	0.000238	CcSEcCtD
Paclitaxel—Rhinitis—Epirubicin—ovarian cancer	7.41e-06	0.000237	CcSEcCtD
Paclitaxel—Urinary tract infection—Doxorubicin—ovarian cancer	7.41e-06	0.000237	CcSEcCtD
Paclitaxel—Conjunctivitis—Doxorubicin—ovarian cancer	7.41e-06	0.000237	CcSEcCtD
Paclitaxel—Haemorrhage—Epirubicin—ovarian cancer	7.39e-06	0.000237	CcSEcCtD
Paclitaxel—Hypoaesthesia—Epirubicin—ovarian cancer	7.36e-06	0.000236	CcSEcCtD
Paclitaxel—Pharyngitis—Epirubicin—ovarian cancer	7.34e-06	0.000235	CcSEcCtD
Paclitaxel—Urinary tract disorder—Epirubicin—ovarian cancer	7.3e-06	0.000234	CcSEcCtD
Paclitaxel—Oedema peripheral—Epirubicin—ovarian cancer	7.28e-06	0.000233	CcSEcCtD
Paclitaxel—Hypotension—Docetaxel—ovarian cancer	7.28e-06	0.000233	CcSEcCtD
Paclitaxel—Haematuria—Doxorubicin—ovarian cancer	7.27e-06	0.000233	CcSEcCtD
Paclitaxel—Connective tissue disorder—Epirubicin—ovarian cancer	7.27e-06	0.000233	CcSEcCtD
Paclitaxel—Urethral disorder—Epirubicin—ovarian cancer	7.25e-06	0.000232	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Doxorubicin—ovarian cancer	7.21e-06	0.000231	CcSEcCtD
Paclitaxel—Epistaxis—Doxorubicin—ovarian cancer	7.19e-06	0.00023	CcSEcCtD
Paclitaxel—Sinusitis—Doxorubicin—ovarian cancer	7.15e-06	0.000229	CcSEcCtD
Paclitaxel—Visual impairment—Epirubicin—ovarian cancer	7.12e-06	0.000228	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Docetaxel—ovarian cancer	7.1e-06	0.000227	CcSEcCtD
Paclitaxel—Insomnia—Docetaxel—ovarian cancer	7.04e-06	0.000226	CcSEcCtD
Paclitaxel—Paraesthesia—Docetaxel—ovarian cancer	6.99e-06	0.000224	CcSEcCtD
Paclitaxel—Erythema multiforme—Epirubicin—ovarian cancer	6.99e-06	0.000224	CcSEcCtD
Paclitaxel—Bradycardia—Doxorubicin—ovarian cancer	6.96e-06	0.000223	CcSEcCtD
Paclitaxel—Dyspnoea—Docetaxel—ovarian cancer	6.94e-06	0.000222	CcSEcCtD
Paclitaxel—Somnolence—Docetaxel—ovarian cancer	6.92e-06	0.000222	CcSEcCtD
Paclitaxel—Eye disorder—Epirubicin—ovarian cancer	6.91e-06	0.000221	CcSEcCtD
Paclitaxel—Tinnitus—Epirubicin—ovarian cancer	6.89e-06	0.000221	CcSEcCtD
Paclitaxel—Haemoglobin—Doxorubicin—ovarian cancer	6.88e-06	0.00022	CcSEcCtD
Paclitaxel—Flushing—Epirubicin—ovarian cancer	6.86e-06	0.00022	CcSEcCtD
Paclitaxel—Cardiac disorder—Epirubicin—ovarian cancer	6.86e-06	0.00022	CcSEcCtD
Paclitaxel—Rhinitis—Doxorubicin—ovarian cancer	6.86e-06	0.00022	CcSEcCtD
Paclitaxel—Dyspepsia—Docetaxel—ovarian cancer	6.86e-06	0.00022	CcSEcCtD
Paclitaxel—Haemorrhage—Doxorubicin—ovarian cancer	6.84e-06	0.000219	CcSEcCtD
Paclitaxel—Hypoaesthesia—Doxorubicin—ovarian cancer	6.81e-06	0.000218	CcSEcCtD
Paclitaxel—Pharyngitis—Doxorubicin—ovarian cancer	6.79e-06	0.000217	CcSEcCtD
Paclitaxel—Decreased appetite—Docetaxel—ovarian cancer	6.77e-06	0.000217	CcSEcCtD
Paclitaxel—Urinary tract disorder—Doxorubicin—ovarian cancer	6.76e-06	0.000216	CcSEcCtD
Paclitaxel—Oedema peripheral—Doxorubicin—ovarian cancer	6.74e-06	0.000216	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Docetaxel—ovarian cancer	6.72e-06	0.000215	CcSEcCtD
Paclitaxel—Connective tissue disorder—Doxorubicin—ovarian cancer	6.72e-06	0.000215	CcSEcCtD
Paclitaxel—Fatigue—Docetaxel—ovarian cancer	6.71e-06	0.000215	CcSEcCtD
Paclitaxel—Angiopathy—Epirubicin—ovarian cancer	6.71e-06	0.000215	CcSEcCtD
Paclitaxel—Urethral disorder—Doxorubicin—ovarian cancer	6.71e-06	0.000215	CcSEcCtD
Paclitaxel—Immune system disorder—Epirubicin—ovarian cancer	6.68e-06	0.000214	CcSEcCtD
Paclitaxel—Mediastinal disorder—Epirubicin—ovarian cancer	6.66e-06	0.000213	CcSEcCtD
Paclitaxel—Pain—Docetaxel—ovarian cancer	6.66e-06	0.000213	CcSEcCtD
Paclitaxel—Constipation—Docetaxel—ovarian cancer	6.66e-06	0.000213	CcSEcCtD
Paclitaxel—Chills—Epirubicin—ovarian cancer	6.63e-06	0.000212	CcSEcCtD
Paclitaxel—Arrhythmia—Epirubicin—ovarian cancer	6.6e-06	0.000212	CcSEcCtD
Paclitaxel—Visual impairment—Doxorubicin—ovarian cancer	6.59e-06	0.000211	CcSEcCtD
Paclitaxel—Alopecia—Epirubicin—ovarian cancer	6.53e-06	0.000209	CcSEcCtD
Paclitaxel—Mental disorder—Epirubicin—ovarian cancer	6.48e-06	0.000207	CcSEcCtD
Paclitaxel—Erythema multiforme—Doxorubicin—ovarian cancer	6.47e-06	0.000207	CcSEcCtD
Paclitaxel—Malnutrition—Epirubicin—ovarian cancer	6.44e-06	0.000206	CcSEcCtD
Paclitaxel—Erythema—Epirubicin—ovarian cancer	6.44e-06	0.000206	CcSEcCtD
Paclitaxel—Feeling abnormal—Docetaxel—ovarian cancer	6.42e-06	0.000206	CcSEcCtD
Paclitaxel—Eye disorder—Doxorubicin—ovarian cancer	6.39e-06	0.000205	CcSEcCtD
Paclitaxel—Tinnitus—Doxorubicin—ovarian cancer	6.38e-06	0.000204	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Docetaxel—ovarian cancer	6.37e-06	0.000204	CcSEcCtD
Paclitaxel—Flushing—Doxorubicin—ovarian cancer	6.35e-06	0.000203	CcSEcCtD
Paclitaxel—Cardiac disorder—Doxorubicin—ovarian cancer	6.35e-06	0.000203	CcSEcCtD
Paclitaxel—Flatulence—Epirubicin—ovarian cancer	6.34e-06	0.000203	CcSEcCtD
Paclitaxel—Tension—Epirubicin—ovarian cancer	6.32e-06	0.000202	CcSEcCtD
Paclitaxel—Dysgeusia—Epirubicin—ovarian cancer	6.3e-06	0.000202	CcSEcCtD
Paclitaxel—Nervousness—Epirubicin—ovarian cancer	6.25e-06	0.0002	CcSEcCtD
Paclitaxel—Back pain—Epirubicin—ovarian cancer	6.23e-06	0.000199	CcSEcCtD
Paclitaxel—Angiopathy—Doxorubicin—ovarian cancer	6.21e-06	0.000199	CcSEcCtD
Paclitaxel—Muscle spasms—Epirubicin—ovarian cancer	6.19e-06	0.000198	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—ovarian cancer	6.18e-06	0.000198	CcSEcCtD
Paclitaxel—Mediastinal disorder—Doxorubicin—ovarian cancer	6.17e-06	0.000197	CcSEcCtD
Paclitaxel—Abdominal pain—Docetaxel—ovarian cancer	6.16e-06	0.000197	CcSEcCtD
Paclitaxel—Body temperature increased—Docetaxel—ovarian cancer	6.16e-06	0.000197	CcSEcCtD
Paclitaxel—Chills—Doxorubicin—ovarian cancer	6.14e-06	0.000197	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—ovarian cancer	6.11e-06	0.000196	CcSEcCtD
Paclitaxel—Vision blurred—Epirubicin—ovarian cancer	6.07e-06	0.000194	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—ovarian cancer	6.05e-06	0.000194	CcSEcCtD
Paclitaxel—Mental disorder—Doxorubicin—ovarian cancer	5.99e-06	0.000192	CcSEcCtD
Paclitaxel—Ill-defined disorder—Epirubicin—ovarian cancer	5.97e-06	0.000191	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—ovarian cancer	5.96e-06	0.000191	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—ovarian cancer	5.96e-06	0.000191	CcSEcCtD
Paclitaxel—Anaemia—Epirubicin—ovarian cancer	5.95e-06	0.000191	CcSEcCtD
Paclitaxel—Agitation—Epirubicin—ovarian cancer	5.91e-06	0.000189	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—ovarian cancer	5.87e-06	0.000188	CcSEcCtD
Paclitaxel—Tension—Doxorubicin—ovarian cancer	5.84e-06	0.000187	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—ovarian cancer	5.83e-06	0.000187	CcSEcCtD
Paclitaxel—Malaise—Epirubicin—ovarian cancer	5.8e-06	0.000186	CcSEcCtD
Paclitaxel—Nervousness—Doxorubicin—ovarian cancer	5.78e-06	0.000185	CcSEcCtD
Paclitaxel—Vertigo—Epirubicin—ovarian cancer	5.78e-06	0.000185	CcSEcCtD
Paclitaxel—Syncope—Epirubicin—ovarian cancer	5.77e-06	0.000185	CcSEcCtD
Paclitaxel—Leukopenia—Epirubicin—ovarian cancer	5.76e-06	0.000185	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—ovarian cancer	5.76e-06	0.000184	CcSEcCtD
Paclitaxel—Hypersensitivity—Docetaxel—ovarian cancer	5.74e-06	0.000184	CcSEcCtD
Paclitaxel—Muscle spasms—Doxorubicin—ovarian cancer	5.73e-06	0.000183	CcSEcCtD
Paclitaxel—Palpitations—Epirubicin—ovarian cancer	5.69e-06	0.000182	CcSEcCtD
Paclitaxel—Loss of consciousness—Epirubicin—ovarian cancer	5.66e-06	0.000181	CcSEcCtD
Paclitaxel—Cough—Epirubicin—ovarian cancer	5.62e-06	0.00018	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—ovarian cancer	5.61e-06	0.00018	CcSEcCtD
Paclitaxel—Asthenia—Docetaxel—ovarian cancer	5.59e-06	0.000179	CcSEcCtD
Paclitaxel—Convulsion—Epirubicin—ovarian cancer	5.58e-06	0.000179	CcSEcCtD
Paclitaxel—Hypertension—Epirubicin—ovarian cancer	5.56e-06	0.000178	CcSEcCtD
Paclitaxel—Ill-defined disorder—Doxorubicin—ovarian cancer	5.53e-06	0.000177	CcSEcCtD
Paclitaxel—Pruritus—Docetaxel—ovarian cancer	5.51e-06	0.000176	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—ovarian cancer	5.5e-06	0.000176	CcSEcCtD
Paclitaxel—Myalgia—Epirubicin—ovarian cancer	5.48e-06	0.000175	CcSEcCtD
Paclitaxel—Arthralgia—Epirubicin—ovarian cancer	5.48e-06	0.000175	CcSEcCtD
Paclitaxel—Chest pain—Epirubicin—ovarian cancer	5.48e-06	0.000175	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—ovarian cancer	5.47e-06	0.000175	CcSEcCtD
Paclitaxel—Anxiety—Epirubicin—ovarian cancer	5.46e-06	0.000175	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	5.44e-06	0.000174	CcSEcCtD
Paclitaxel—Discomfort—Epirubicin—ovarian cancer	5.41e-06	0.000173	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—ovarian cancer	5.37e-06	0.000172	CcSEcCtD
Paclitaxel—Dry mouth—Epirubicin—ovarian cancer	5.36e-06	0.000172	CcSEcCtD
Paclitaxel—Vertigo—Doxorubicin—ovarian cancer	5.35e-06	0.000171	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—ovarian cancer	5.34e-06	0.000171	CcSEcCtD
Paclitaxel—Leukopenia—Doxorubicin—ovarian cancer	5.33e-06	0.000171	CcSEcCtD
Paclitaxel—Diarrhoea—Docetaxel—ovarian cancer	5.33e-06	0.000171	CcSEcCtD
Paclitaxel—Confusional state—Epirubicin—ovarian cancer	5.3e-06	0.00017	CcSEcCtD
Paclitaxel—Palpitations—Doxorubicin—ovarian cancer	5.26e-06	0.000169	CcSEcCtD
Paclitaxel—Anaphylactic shock—Epirubicin—ovarian cancer	5.25e-06	0.000168	CcSEcCtD
Paclitaxel—Oedema—Epirubicin—ovarian cancer	5.25e-06	0.000168	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—ovarian cancer	5.23e-06	0.000168	CcSEcCtD
Paclitaxel—Infection—Epirubicin—ovarian cancer	5.22e-06	0.000167	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—ovarian cancer	5.2e-06	0.000166	CcSEcCtD
Paclitaxel—Shock—Epirubicin—ovarian cancer	5.17e-06	0.000166	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—ovarian cancer	5.16e-06	0.000165	CcSEcCtD
Paclitaxel—Nervous system disorder—Epirubicin—ovarian cancer	5.15e-06	0.000165	CcSEcCtD
Paclitaxel—Dizziness—Docetaxel—ovarian cancer	5.15e-06	0.000165	CcSEcCtD
Paclitaxel—Thrombocytopenia—Epirubicin—ovarian cancer	5.14e-06	0.000165	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—ovarian cancer	5.14e-06	0.000165	CcSEcCtD
Paclitaxel—Tachycardia—Epirubicin—ovarian cancer	5.13e-06	0.000164	CcSEcCtD
Paclitaxel—Skin disorder—Epirubicin—ovarian cancer	5.1e-06	0.000163	CcSEcCtD
Paclitaxel—Hyperhidrosis—Epirubicin—ovarian cancer	5.08e-06	0.000163	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—ovarian cancer	5.07e-06	0.000162	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—ovarian cancer	5.07e-06	0.000162	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—ovarian cancer	5.07e-06	0.000162	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—ovarian cancer	5.05e-06	0.000162	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	5.03e-06	0.000161	CcSEcCtD
Paclitaxel—Discomfort—Doxorubicin—ovarian cancer	5.01e-06	0.00016	CcSEcCtD
Paclitaxel—Anorexia—Epirubicin—ovarian cancer	5.01e-06	0.00016	CcSEcCtD
Paclitaxel—Dry mouth—Doxorubicin—ovarian cancer	4.96e-06	0.000159	CcSEcCtD
Paclitaxel—Vomiting—Docetaxel—ovarian cancer	4.95e-06	0.000159	CcSEcCtD
Paclitaxel—Rash—Docetaxel—ovarian cancer	4.91e-06	0.000157	CcSEcCtD
Paclitaxel—Hypotension—Epirubicin—ovarian cancer	4.91e-06	0.000157	CcSEcCtD
Paclitaxel—Dermatitis—Docetaxel—ovarian cancer	4.91e-06	0.000157	CcSEcCtD
Paclitaxel—Confusional state—Doxorubicin—ovarian cancer	4.9e-06	0.000157	CcSEcCtD
Paclitaxel—Headache—Docetaxel—ovarian cancer	4.88e-06	0.000156	CcSEcCtD
Paclitaxel—Anaphylactic shock—Doxorubicin—ovarian cancer	4.86e-06	0.000156	CcSEcCtD
Paclitaxel—Oedema—Doxorubicin—ovarian cancer	4.86e-06	0.000156	CcSEcCtD
Paclitaxel—Infection—Doxorubicin—ovarian cancer	4.83e-06	0.000155	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.79e-06	0.000153	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—ovarian cancer	4.78e-06	0.000153	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—ovarian cancer	4.77e-06	0.000153	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—ovarian cancer	4.76e-06	0.000152	CcSEcCtD
Paclitaxel—Insomnia—Epirubicin—ovarian cancer	4.75e-06	0.000152	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—ovarian cancer	4.74e-06	0.000152	CcSEcCtD
Paclitaxel—Skin disorder—Doxorubicin—ovarian cancer	4.72e-06	0.000151	CcSEcCtD
Paclitaxel—Paraesthesia—Epirubicin—ovarian cancer	4.72e-06	0.000151	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—ovarian cancer	4.7e-06	0.00015	CcSEcCtD
Paclitaxel—Dyspnoea—Epirubicin—ovarian cancer	4.68e-06	0.00015	CcSEcCtD
Paclitaxel—Somnolence—Epirubicin—ovarian cancer	4.67e-06	0.00015	CcSEcCtD
Paclitaxel—Anorexia—Doxorubicin—ovarian cancer	4.63e-06	0.000148	CcSEcCtD
Paclitaxel—Nausea—Docetaxel—ovarian cancer	4.63e-06	0.000148	CcSEcCtD
Paclitaxel—Dyspepsia—Epirubicin—ovarian cancer	4.62e-06	0.000148	CcSEcCtD
Paclitaxel—Decreased appetite—Epirubicin—ovarian cancer	4.57e-06	0.000146	CcSEcCtD
Paclitaxel—Hypotension—Doxorubicin—ovarian cancer	4.54e-06	0.000145	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.53e-06	0.000145	CcSEcCtD
Paclitaxel—Fatigue—Epirubicin—ovarian cancer	4.53e-06	0.000145	CcSEcCtD
Paclitaxel—Constipation—Epirubicin—ovarian cancer	4.49e-06	0.000144	CcSEcCtD
Paclitaxel—Pain—Epirubicin—ovarian cancer	4.49e-06	0.000144	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	4.43e-06	0.000142	CcSEcCtD
Paclitaxel—Insomnia—Doxorubicin—ovarian cancer	4.4e-06	0.000141	CcSEcCtD
Paclitaxel—Paraesthesia—Doxorubicin—ovarian cancer	4.36e-06	0.00014	CcSEcCtD
Paclitaxel—Dyspnoea—Doxorubicin—ovarian cancer	4.33e-06	0.000139	CcSEcCtD
Paclitaxel—Feeling abnormal—Epirubicin—ovarian cancer	4.33e-06	0.000139	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—ovarian cancer	4.32e-06	0.000138	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Epirubicin—ovarian cancer	4.3e-06	0.000138	CcSEcCtD
Paclitaxel—Dyspepsia—Doxorubicin—ovarian cancer	4.28e-06	0.000137	CcSEcCtD
Paclitaxel—Decreased appetite—Doxorubicin—ovarian cancer	4.22e-06	0.000135	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—ovarian cancer	4.2e-06	0.000134	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—ovarian cancer	4.19e-06	0.000134	CcSEcCtD
Paclitaxel—Urticaria—Epirubicin—ovarian cancer	4.17e-06	0.000134	CcSEcCtD
Paclitaxel—Pain—Doxorubicin—ovarian cancer	4.16e-06	0.000133	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—ovarian cancer	4.16e-06	0.000133	CcSEcCtD
Paclitaxel—Abdominal pain—Epirubicin—ovarian cancer	4.15e-06	0.000133	CcSEcCtD
Paclitaxel—Body temperature increased—Epirubicin—ovarian cancer	4.15e-06	0.000133	CcSEcCtD
Paclitaxel—Feeling abnormal—Doxorubicin—ovarian cancer	4.01e-06	0.000128	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.97e-06	0.000127	CcSEcCtD
Paclitaxel—Hypersensitivity—Epirubicin—ovarian cancer	3.87e-06	0.000124	CcSEcCtD
Paclitaxel—Urticaria—Doxorubicin—ovarian cancer	3.86e-06	0.000124	CcSEcCtD
Paclitaxel—Abdominal pain—Doxorubicin—ovarian cancer	3.84e-06	0.000123	CcSEcCtD
Paclitaxel—Body temperature increased—Doxorubicin—ovarian cancer	3.84e-06	0.000123	CcSEcCtD
Paclitaxel—Asthenia—Epirubicin—ovarian cancer	3.77e-06	0.000121	CcSEcCtD
Paclitaxel—Pruritus—Epirubicin—ovarian cancer	3.72e-06	0.000119	CcSEcCtD
Paclitaxel—Diarrhoea—Epirubicin—ovarian cancer	3.59e-06	0.000115	CcSEcCtD
Paclitaxel—Hypersensitivity—Doxorubicin—ovarian cancer	3.58e-06	0.000115	CcSEcCtD
Paclitaxel—Asthenia—Doxorubicin—ovarian cancer	3.49e-06	0.000112	CcSEcCtD
Paclitaxel—Dizziness—Epirubicin—ovarian cancer	3.47e-06	0.000111	CcSEcCtD
Paclitaxel—Pruritus—Doxorubicin—ovarian cancer	3.44e-06	0.00011	CcSEcCtD
Paclitaxel—Vomiting—Epirubicin—ovarian cancer	3.34e-06	0.000107	CcSEcCtD
Paclitaxel—Diarrhoea—Doxorubicin—ovarian cancer	3.33e-06	0.000107	CcSEcCtD
Paclitaxel—Rash—Epirubicin—ovarian cancer	3.31e-06	0.000106	CcSEcCtD
Paclitaxel—Dermatitis—Epirubicin—ovarian cancer	3.31e-06	0.000106	CcSEcCtD
Paclitaxel—Headache—Epirubicin—ovarian cancer	3.29e-06	0.000105	CcSEcCtD
Paclitaxel—Dizziness—Doxorubicin—ovarian cancer	3.21e-06	0.000103	CcSEcCtD
Paclitaxel—Nausea—Epirubicin—ovarian cancer	3.12e-06	9.99e-05	CcSEcCtD
Paclitaxel—Vomiting—Doxorubicin—ovarian cancer	3.09e-06	9.9e-05	CcSEcCtD
Paclitaxel—Rash—Doxorubicin—ovarian cancer	3.06e-06	9.81e-05	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—ovarian cancer	3.06e-06	9.81e-05	CcSEcCtD
Paclitaxel—Headache—Doxorubicin—ovarian cancer	3.04e-06	9.75e-05	CcSEcCtD
Paclitaxel—Nausea—Doxorubicin—ovarian cancer	2.89e-06	9.25e-05	CcSEcCtD
Paclitaxel—BCL2—Immune System—PIK3CD—ovarian cancer	1.42e-06	7.47e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.41e-06	7.43e-05	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—ovarian cancer	1.41e-06	7.42e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—KRAS—ovarian cancer	1.41e-06	7.41e-05	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—MYC—ovarian cancer	1.4e-06	7.39e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—FASN—ovarian cancer	1.4e-06	7.37e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.39e-06	7.35e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PPP2R1A—ovarian cancer	1.39e-06	7.35e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—SLC2A1—ovarian cancer	1.38e-06	7.27e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NME2—ovarian cancer	1.38e-06	7.25e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—SLC5A5—ovarian cancer	1.38e-06	7.25e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—SLC2A1—ovarian cancer	1.37e-06	7.24e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.37e-06	7.23e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.36e-06	7.16e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.35e-06	7.12e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.34e-06	7.09e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYTB—ovarian cancer	1.34e-06	7.09e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—SLC2A1—ovarian cancer	1.33e-06	7e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.32e-06	6.98e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CYP1B1—ovarian cancer	1.32e-06	6.97e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP1B1—ovarian cancer	1.32e-06	6.94e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.31e-06	6.92e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.3e-06	6.85e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—PIK3CA—ovarian cancer	1.29e-06	6.81e-05	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—ovarian cancer	1.29e-06	6.78e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—FASN—ovarian cancer	1.27e-06	6.7e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—FASN—ovarian cancer	1.26e-06	6.64e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.26e-06	6.63e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—BRIP1—ovarian cancer	1.26e-06	6.63e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ERBB2—ovarian cancer	1.25e-06	6.59e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.25e-06	6.59e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.24e-06	6.54e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MTOR—ovarian cancer	1.23e-06	6.51e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CB—ovarian cancer	1.23e-06	6.51e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CAV1—ovarian cancer	1.21e-06	6.4e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.21e-06	6.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.2e-06	6.31e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.2e-06	6.3e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HRAS—ovarian cancer	1.2e-06	6.3e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.17e-06	6.19e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.17e-06	6.19e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	1.17e-06	6.18e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPP2R1A—ovarian cancer	1.17e-06	6.15e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.17e-06	6.15e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.16e-06	6.12e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.16e-06	6.11e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CDKN1B—ovarian cancer	1.16e-06	6.11e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.16e-06	6.11e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.15e-06	6.05e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—IL6—ovarian cancer	1.14e-06	6.03e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CAV1—ovarian cancer	1.14e-06	6.02e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL2—ovarian cancer	1.13e-06	5.98e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.13e-06	5.96e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPP2R1A—ovarian cancer	1.13e-06	5.95e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.12e-06	5.92e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—YAP1—ovarian cancer	1.12e-06	5.89e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TERT—ovarian cancer	1.11e-06	5.84e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	1.11e-06	5.83e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.1e-06	5.8e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CTNNB1—ovarian cancer	1.09e-06	5.77e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.09e-06	5.75e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ABCB1—ovarian cancer	1.09e-06	5.74e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ABCB1—ovarian cancer	1.08e-06	5.71e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.08e-06	5.67e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.08e-06	5.67e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—TYMS—ovarian cancer	1.07e-06	5.64e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PTEN—ovarian cancer	1.07e-06	5.62e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—TYMS—ovarian cancer	1.06e-06	5.61e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—AKT1—ovarian cancer	1.06e-06	5.56e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.05e-06	5.54e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ABCB1—ovarian cancer	1.05e-06	5.53e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CG—ovarian cancer	1.04e-06	5.48e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—TYMS—ovarian cancer	1.03e-06	5.43e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.03e-06	5.42e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CAV1—ovarian cancer	1.02e-06	5.4e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.02e-06	5.37e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.02e-06	5.36e-05	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—AKT1—ovarian cancer	9.72e-07	5.12e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	9.72e-07	5.12e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6ST—ovarian cancer	9.71e-07	5.12e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—YAP1—ovarian cancer	9.68e-07	5.1e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.58e-07	5.05e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—STAT3—ovarian cancer	9.54e-07	5.03e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ABCB1—ovarian cancer	9.54e-07	5.03e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NRAS—ovarian cancer	9.52e-07	5.02e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ABCB1—ovarian cancer	9.45e-07	4.98e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—TYMS—ovarian cancer	9.37e-07	4.94e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.34e-07	4.92e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—APC—ovarian cancer	9.33e-07	4.92e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—TYMS—ovarian cancer	9.29e-07	4.89e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CD—ovarian cancer	9.14e-07	4.82e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MAPK3—ovarian cancer	9.12e-07	4.8e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—FASN—ovarian cancer	9.11e-07	4.8e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.03e-07	4.76e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SLC5A5—ovarian cancer	8.96e-07	4.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYTB—ovarian cancer	8.86e-07	4.67e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MAPK1—ovarian cancer	8.67e-07	4.57e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—ovarian cancer	8.67e-07	4.57e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SLC2A1—ovarian cancer	8.66e-07	4.56e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CAV1—ovarian cancer	8.62e-07	4.54e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CAV1—ovarian cancer	8.58e-07	4.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.56e-07	4.51e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	8.47e-07	4.46e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—YAP1—ovarian cancer	8.43e-07	4.45e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.42e-07	4.44e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP1B1—ovarian cancer	8.3e-07	4.37e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CAV1—ovarian cancer	8.3e-07	4.37e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.23e-07	4.34e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CD—ovarian cancer	8.2e-07	4.32e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.2e-07	4.32e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—ovarian cancer	8.19e-07	4.32e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CB—ovarian cancer	7.97e-07	4.2e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.93e-07	4.18e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—FASN—ovarian cancer	7.89e-07	4.16e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—YAP1—ovarian cancer	7.88e-07	4.15e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CG—ovarian cancer	7.85e-07	4.14e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CG—ovarian cancer	7.81e-07	4.12e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.8e-07	4.11e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SLC5A5—ovarian cancer	7.76e-07	4.09e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.75e-07	4.08e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.75e-07	4.08e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.63e-07	4.02e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CG—ovarian cancer	7.56e-07	3.98e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CAV1—ovarian cancer	7.55e-07	3.98e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CA—ovarian cancer	7.53e-07	3.97e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SLC2A1—ovarian cancer	7.5e-07	3.95e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CAV1—ovarian cancer	7.48e-07	3.94e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	7.36e-07	3.88e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.34e-07	3.87e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTEN—ovarian cancer	7.32e-07	3.86e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERBB2—ovarian cancer	7.25e-07	3.82e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP1B1—ovarian cancer	7.19e-07	3.79e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MTOR—ovarian cancer	7.15e-07	3.77e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CB—ovarian cancer	7.15e-07	3.77e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—ovarian cancer	6.96e-07	3.67e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CD—ovarian cancer	6.9e-07	3.64e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTEN—ovarian cancer	6.89e-07	3.63e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CG—ovarian cancer	6.88e-07	3.62e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—FASN—ovarian cancer	6.88e-07	3.62e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CD—ovarian cancer	6.87e-07	3.62e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.86e-07	3.61e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ABCB1—ovarian cancer	6.83e-07	3.6e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CG—ovarian cancer	6.82e-07	3.59e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.76e-07	3.57e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TYMS—ovarian cancer	6.71e-07	3.54e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1B—ovarian cancer	6.71e-07	3.54e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—ovarian cancer	6.66e-07	3.51e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CD—ovarian cancer	6.64e-07	3.5e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.53e-07	3.44e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—FASN—ovarian cancer	6.42e-07	3.39e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	6.38e-07	3.36e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.34e-07	3.34e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CTNNB1—ovarian cancer	6.34e-07	3.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC5A5—ovarian cancer	6.32e-07	3.33e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.26e-07	3.3e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTEN—ovarian cancer	6.18e-07	3.26e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—ovarian cancer	6.15e-07	3.24e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC2A1—ovarian cancer	6.1e-07	3.22e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CD—ovarian cancer	6.04e-07	3.19e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CB—ovarian cancer	6.01e-07	3.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CD—ovarian cancer	5.99e-07	3.16e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CB—ovarian cancer	5.99e-07	3.16e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.98e-07	3.15e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ABCB1—ovarian cancer	5.92e-07	3.12e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.85e-07	3.08e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TYMS—ovarian cancer	5.81e-07	3.06e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CB—ovarian cancer	5.79e-07	3.05e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.55e-07	2.93e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—ovarian cancer	5.53e-07	2.91e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—ovarian cancer	5.51e-07	2.91e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CAV1—ovarian cancer	5.41e-07	2.85e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK3—ovarian cancer	5.28e-07	2.78e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CB—ovarian cancer	5.27e-07	2.78e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CB—ovarian cancer	5.22e-07	2.75e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—YAP1—ovarian cancer	5.2e-07	2.74e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTEN—ovarian cancer	5.2e-07	2.74e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.19e-07	2.74e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTEN—ovarian cancer	5.17e-07	2.73e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.16e-07	2.72e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	5.16e-07	2.72e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—ovarian cancer	5.13e-07	2.71e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TYMS—ovarian cancer	5.06e-07	2.67e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK1—ovarian cancer	5.02e-07	2.65e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—ovarian cancer	5.02e-07	2.65e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTEN—ovarian cancer	5e-07	2.64e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CG—ovarian cancer	4.93e-07	2.6e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—ovarian cancer	4.86e-07	2.56e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.82e-07	2.54e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—ovarian cancer	4.74e-07	2.5e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TYMS—ovarian cancer	4.73e-07	2.49e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CAV1—ovarian cancer	4.68e-07	2.47e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTEN—ovarian cancer	4.55e-07	2.4e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTEN—ovarian cancer	4.51e-07	2.38e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.48e-07	2.36e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—ovarian cancer	4.36e-07	2.3e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CD—ovarian cancer	4.33e-07	2.28e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4.27e-07	2.25e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—FASN—ovarian cancer	4.24e-07	2.23e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—ovarian cancer	4.22e-07	2.22e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.17e-07	2.2e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CAV1—ovarian cancer	4.08e-07	2.15e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—ovarian cancer	4.03e-07	2.13e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.02e-07	2.12e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—ovarian cancer	3.97e-07	2.09e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—ovarian cancer	3.86e-07	2.03e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.86e-07	2.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CAV1—ovarian cancer	3.81e-07	2.01e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CB—ovarian cancer	3.78e-07	1.99e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.75e-07	1.98e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.72e-07	1.96e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—ovarian cancer	3.67e-07	1.93e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—ovarian cancer	3.65e-07	1.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.64e-07	1.92e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—ovarian cancer	3.56e-07	1.88e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—ovarian cancer	3.53e-07	1.86e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.47e-07	1.83e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.42e-07	1.8e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.27e-07	1.72e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.27e-07	1.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTEN—ovarian cancer	3.26e-07	1.72e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—ovarian cancer	3.21e-07	1.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—ovarian cancer	3.18e-07	1.68e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.18e-07	1.67e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TYMS—ovarian cancer	3.12e-07	1.64e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.05e-07	1.61e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—ovarian cancer	2.99e-07	1.58e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—ovarian cancer	2.98e-07	1.57e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—ovarian cancer	2.88e-07	1.52e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.85e-07	1.5e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTEN—ovarian cancer	2.83e-07	1.49e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.66e-07	1.4e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—ovarian cancer	2.62e-07	1.38e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—ovarian cancer	2.6e-07	1.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CAV1—ovarian cancer	2.51e-07	1.33e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTEN—ovarian cancer	2.46e-07	1.3e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.3e-07	1.21e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTEN—ovarian cancer	2.3e-07	1.21e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.29e-07	1.21e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.01e-07	1.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.99e-07	1.05e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—ovarian cancer	1.88e-07	9.91e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.76e-07	9.25e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.74e-07	9.15e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—ovarian cancer	1.63e-07	8.58e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.62e-07	8.55e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTEN—ovarian cancer	1.52e-07	7.99e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—ovarian cancer	1.42e-07	7.48e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—ovarian cancer	1.33e-07	6.99e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.07e-07	5.64e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—ovarian cancer	8.74e-08	4.61e-06	CbGpPWpGaD
